TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedN/A

Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders

The purpose of this prospective, participant-blinded trial is to determine the changes in sleep architecture in a cohort of subjects who have undergone deep brain stimulation (DBS) surgery for treatment of movement disorders such as moderat

Birmingham, Alabama, United StatesView details
UnknownN/A

Effect of WB-EMS on Parkinson's Disease

The aim is to establish adequate and suitable protocols for PD patients and to determine the WB-EMS effects on muscle strength, balance, walking, cognitive functions,neurotrophic factors and alpha-synuclein. Thirty-six PD patients, aged fro

Campobasso, ItalyView details
CompletedPhase 3

Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone

Parkinson's disease (PD) is the second most common neurodegenerative disease in the US, affecting nearly 1 million Americans. Up to 82% of community dwelling individuals with PD complain of sleep disturbances, typically sleep fragmentation.

Suwanee, Georgia, United States+3 moreView details
Unknown

The Measurement of Nocturnal Hypokinesia in Parkinson's Disease (PD) Patient Compared With Spouse by Wearable Sensors

To quantitative measurement of nocturnal hypokinesia of Parkinson's disease patients compares with their spouses by using multisite accelerometers for 1 night at their home. To determine whether the nocturnal movement of Parkinson's disease

Bangkok, Bangkok, ThailandView details
Completed

Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's Disease

The overarching goal of this prospective cohort study is to test the hypotheses that greater severity of hyposmia is associated with increased risk of cognitive decline in PD and that worsening hyposmia parallels progressive cholinergic lim

Ann Arbor, Michigan, United StatesView details
Completed

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

DaTscanTM Ioflupane I123, a radiopharmaceutical will be used as an adjunct diagnostic tool in combination with single photon emission computed tomography (SPECT) to evaluate striatal dopamine transporter (DAT) distribution in patients with

Lexington, Kentucky, United StatesView details
TerminatedPhase 2

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

Primary Objectives: * Part 1: To determine the safety and tolerability of 4, 8, and 15 milligrams of GZ/SAR402671 (venglustat) administered orally for 4 weeks, as compared to placebo in participants with early-stage Parkinson's disease (PD

Scottsdale, Arizona, United States+51 moreView details
CompletedPhase 3

Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients

Patients with Parkinson's disease who completed the prior double-blind study 6002-009 are eligible to enter into this long-term study. The purpose of this study is to evaluate the safety and efficacy of KW-6002 administered long-term in pat

Tokyo, JapanView details
Not yet recruitingN/A

Expiratory Muscle Training in Parkinson's Disease With Forward Trunk Flexion

Postural abnormalities (PA) negatively affecting the axial system are part of the symptoms of Parkinson's disease (PD). They occur in more than 20% of patients with PD especially in more advanced stages of the disease, contribute significan

Prague, CzechiaView details
CompletedPhase 1

Refining Cough Skill Training in Parkinson's Disease and Dysphagia

Airway protection deficits (cough and swallowing) are prevalent and pervasive in Parkinson's disease (PD), contributing to adverse health outcomes like pneumonia. This study aims to refine cough skill training by examining whether variable

New York, New York, United StatesView details
CompletedPhase 1

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

To study the profile of Neupro patch administrated at 2 mg, 4 mg, 6 mg and 8 mg/day weekly in patients with early-stage Parkinson's disease

Long Beach, California, United States+2 moreView details
Recruiting

Natural History Protocol for Movement Disorders

Background: A movement disorder is a condition that causes a person s body to move in ways that are not normal. There are different types.

Bethesda, Maryland, United StatesView details
UnknownPhase 1

Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease

Parkinson's disease patients may have severe non-motor symptoms. A common and troublesome non-motor symptom is pain.

Multiple locationsView details
UnknownPhase 4

The Use of Botox in Advanced Parkinson's Patients Experiencing Pain

Most Parkinsonism related pain can be assigned to one or more of five categories: musculoskeletal pain, neuritic or radicular pain, dystonia associated pain, primary or central pain, and akathitic discomfort. In PD pain tends to affect the

Multiple locationsView details
RecruitingN/A

Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners

The goal of this feasibility study and clinical trial is to learn if an evidenced-based breathwork and meditation intervention (SKY Breath) will improve the mental and physical well-being of individuals with Parkinson's Disease (iPD) in sta

Coral Springs, Florida, United States+2 moreView details
CompletedN/A

Nature-based Therapy Program for Parkinson's Disease (PARC)

The goal of this clinical trial is to learn if a nature-based program has positive effects on the physical and psychosocial health in a group of participants with Parkinson's disease. The main questions it aims to answer are: Will the prog

Saguenay, Quebec, CanadaView details
CompletedPhase 2

Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo treatment.

Tampa, Florida, United StatesView details
CompletedN/A

Agility Training in Parkinson's Disease

To determine the effects of an unusually highly intensity and individualized sensorimotor and visuomotor agility exercise program on non-demented PD patients' clinical symptoms, mobility, and postural stability.

Kaposvár, Somogy County, HungaryView details
CompletedPhase 2

Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment

Disabling symptoms of blood pressure dysregulation, impaired swallowing and digestion are common amongst Parkinson's patients. So far the exact pathophysiology for this is not fully understood.

Zurich, Canton of Zurich, SwitzerlandView details
UnknownN/A

Evaluate the Effectiveness and Safety of Variable Frequency Stimulation Compared With Constant Frequency Stimulation for Patients With Idiopathic Parkinson's Disease

In the VFS paradigm the stimulation frequency was set to alternate between high and low frequencies, where the frequency of stimulation or frequency combinations can be changed instantaneously according to damage of the moment rhythms. Vari

Beijing, Beijing Municipality, China+8 moreView details
Load more trials